Northlane Capital Partners Closes Fund II at $408 Million
Northlane Capital Partners ("Northlane" or “NCP”), a middle market private equity firm targeting investments in healthcare and business services, today announced that is has successfully raised its second independent fund, Northlane Capital Partners II, L.P. ("NCP II" or "Fund II"). NCP II closed on total capital commitments of $408 million, exceeding its target of $375 million, and attracted strong interest from a diverse group of investors, including public pension funds, asset managers, insurance companies, high net worth families, foundations, and former portfolio company executives.
Northlane Capital Partners Invests in Empower Community Care
Northlane Capital Partners (“NCP”), announced today that is has made an investment in Empower Community Care ("Empower"), a leading global behavioral health organization responsible for distributing evidence-based programs and technologies.
Northlane Capital Partners Announces Promotion and Addition of Director of Business Development
Northlane Capital Partners (“NCP”), a middle market private equity firm focused on key segments within the healthcare and business services sectors, announced today the promotion of JJ Carbonell to Principal and the addition of Rich Grant as Director of Business Development.
Northlane Capital Partners Recognized as one of 2021’s Top Private Equity Firms in the Middle Market
Northlane Capital Partners is pleased to announce our inclusion in the 2021 list of the TOP 50 PE Firms in the Middle Market as determined annually by GCI Publishing. The list recognizes small and mid-sized private equity firms with exceptional track records, accomplished teams, and highly respected industry reputations.
More about Northlane and the full list of PE firms can be viewed here
VMG Health Acquires Health Care Futures, a Business Strategy and Consulting Firm
VMG Health, the market leader in providing full-service healthcare transaction advisory and consulting, is pleased to announce it has acquired Health Care Futures, a business strategy and consulting firm with offices in Minneapolis and Chicago. The transaction was recently closed, and the two firms will be fully integrated in the first quarter of 2021. VMG Health is owned by VMG Employees and Northlane Capital Partners, LLC (“NCP”). NCP invested in the company in March 2020.
VMG Health Acquires RR Health Strategies, a Medical Coding, Compliance, and Operational Excellence Firm
VMG Health, a leading full-service healthcare valuation and transaction advisory firm, is pleased to announce it has acquired RR Health Strategies, LLC (“RRHS”), a medical coding, compliance, and operational excellence management consulting firm based in Hauppauge, New York. VMG Health is a portfolio company of Northlane Capital Partners, LLC (“NCP”), which invested in VMG Health in March 2020.
Northlane Capital Partners’ Portfolio Company SmartWave Technologies Acquires Multi-Tech Systems
Northlane Capital Partners (“NCP”) announced today that its portfolio company, SmartWave Technologies, has acquired Multi-Tech Systems, Inc., a leading global supplier of industrial communication devices and services. The acquisition will result in an integrated, end-to-end provider of innovative IoT solutions designed for process optimization in service-heavy industries with a significant presence in the hygiene market. The combined entity will operate under the MultiTech brand.
Northlane Capital Partners Named to Inc.’s 2020 Private Equity 50 List
Northlane Capital Partners is proud to announce that our firm has been named to the second annual Inc. Private Equity 50 list, honoring the most founder-friendly PE firms that help businesses thrive, even in the face of unprecedented challenges. The final list recognizes 50 firms that entrepreneurs can trust, collaborate with on new strategies, and can help finance investments and acquisitions. The list has become a go-to guide for entrepreneurs who want to grow their companies while retaining an ownership stake – all 50 have a successful track record of backing entrepreneurs.
The full list of PE firms and accompanying article can be viewed here
Northlane Capital Partners Invests in VMG Health
Northlane Capital Partners (“NCP”) announced today that it has made an investment in VMG Health (“VMG”), a leading full-service valuation and transaction advisory firm exclusively focused on the healthcare industry. NCP invested in partnership with VMG’s existing management team and key employees, led by Founder and CEO Greg Koonsman.
Discovery Data Names Robert Skea as Chief Executive Officer
We are pleased to announce that Robert Skea has been appointed as the CEO of Discovery Data.
NCP Promotes Scott Kauffman to Partner and Adds to Team
We are pleased to announce the promotion of Scott Kauffman to Partner.
Mr. Kauffman initially joined the team as an Associate in 2004 and rejoined in 2008 after completing business school. He began his career as an investment banking analyst at BB&T Capital Markets. Mr. Kauffman received an M.B.A. from the Stanford University Graduate School of Business and a B.S. in Business Administration, magna cum laude, from the University of Richmond.
We also have three recent additions to the team. Charles Donahue recently joined the firm as a Senior Associate, having previously worked at Arsenal Capital Partners. In addition, Anna Ellingboe, previously with Piper Jaffray, and David Spiritos, previously with Robert W. Baird, both recently joined as Associates.
Investment in Discovery Data
We invested in Discovery Data Holdings, Inc. ("Discovery Data"), a provider of information services used to identify and reach firms and professionals in the financial services and insurance industries for effective product distribution, recruitment, and targeted marketing campaigns. Discovery Data provides a SaaS solution to asset managers, wealth advisors, insurance companies, financial technology and service providers, including profiles of 2.3 million professionals and 40,000 firms, and workflow software applications.
Investment in Firma Clinical Research
We invested in Firma Clinical Research, a niche contract research organization providing services to the biopharmaceutical industry. Firma provides support services to biopharmaceutical and medical device companies as part of the drug and product development process, most notably in the areas of remote patient visit and data management/biostatistical services.
List Partners Completes Two Acquisitions
List Partners, LLC, a portfolio company of NCP that provides sales intelligence content and information services under the brand name Winmo, successfully completed the acquisitions of two sales intelligence platforms: Access Confidential and Redbooks.
Investment in List Partners
We invested in List Partners, a a provider of sales intelligence content used by business development professionals who target national advertisers and their agencies across the U.S. and the U.K.
Investment in SmartWave Technologies
We invested in SmartWave Technologies, a market-leading manufacturer of innovative electronic and electromechanical systems for a broad range of end markets, including the away-from-home restroom market. Founded in 1994, SmartWave designs components for products that require sensing, verifying, or dispensing on behalf of companies in the healthcare, hygiene, sanitary, plumbing supply and other end markets. SmartWave adds value to customers' products by incorporating technology that improves the product functionality and enhances the end user experience.
Linden and Northlane Complete Merger of Schulman IRB and Chesapeake IRB to Create Advarra
Linden Capital Partners and Northlane Capital Partners completed the merger of their portfolio companies Chesapeake IRB and Schulman IRB, respectively, to create Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), and research compliance services in North America.
Investment in PAR Excellence Systems
We invested in PAR Excellence Systems, a market leader in specialized supply chain management systems for the healthcare industry. Headquartered in Cincinnati, OH, PAR Excellence Systems offers comprehensive inventory management systems and related support services that enable healthcare organizations to fully automate inventory replenishment activities and generate real-time, system-wide inventory visibility. The systems also simplify the caregivers’ day-to-day tasks and allow them to focus on their core objective of patient care.
Northlane Capital Partners Spins out from American Capital
We announced our spinout from American Capital, Ltd. in connection with Ares Capital Corporation’s (Nasdaq: ARCC) acquisition of American Capital effective January 3, 2017.
Brandmuscle Invests in Saepio Technologies
Brandmuscle, an NCP portfolio company, made an investment in Saepio Technologies, a provider of marketing management software. Saepio Technologies complements Brandmuscle’s current local marketing offerings to create the largest and most comprehensive suite of software and services to support global brands that sell through distributed networks of dealers, agents and franchisees.
Investment in Brandmuscle
We invested in Brandmuscle, a leading provider of local marketing automation technology and services. Headquartered in Chicago and with offices in Cleveland, Austin and New Jersey, Brandmuscle provides software and services that enable brands with distributed sales and marketing channels to easily create and execute brand-compliant, local marketing campaigns across all mediums and formats. Brandmuscle employs more than 650 professionals and serves more than 200 of the world's leading brands.
Sale of Mirion Technologies
Mirion Technologies, Inc. (“Mirion”) was sold to Charterhouse Capital Partners, LLP for $750 million. Mirion is a global provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear power, medical, military and homeland security markets. Mirion was created in December 2005 through the merger of three companies: synOdys, Global Dosimetry Solutions (GDS) and Imaging and Sensing Technology (IST). Headquartered in San Ramon, CA, Mirion has 13 facilities across North America, Europe and Asia and employs more than 1,000 people.
Investment in Schulman IRB
We invested in Schulman IRB, a leading independent Institutional Review Board ("IRB") that provides clinical trial oversight services to pharmaceutical firms, contract research organizations, hospitals and academic medical centers throughout the United States and Canada. Founded in 1983 and based in Cincinnati, Ohio, Schulman IRB is one of the largest IRBs in the United States. The Company primarily serves the pharmaceutical and medical device industries as a central IRB on research involving drugs, medical devices and biologics. Schulman reviews research protocols and consent documents from clinical trials to evaluate compliance with human subject protection regulations. Schulman is fully accredited by the Association for the Accreditation of Human Research Protection Programs.
Sale of Avalon Laboratories
Avalon Laboratories ("Avalon" or the "Company) was sold to Nordson Corporation (Nasdaq: NDSN), the world's leading precision fluid dispensing systems manufacturer, for $180 million. Avalon is a leading designer and manufacturer of highly-specialized, single-use catheters and specialty medical tubing products for cardiology, pulmonology and related applications. Avalon's devices are life-critical components that provide connections between patients and life support machines. The Company serves OEM customers in the cardiology, pulmonology, endovascular, bariatrics, tracheostomy, endoscopy, non-vascular stent and ophthalmic markets segments. Avalon is headquartered in Los Angeles, CA and has a FDA and ISO 13485 registered manufacturing facility in Guaymas, Mexico.
Final Close of $1 Billion Lower Middle Market Fund
The fund’s LPs include sovereign wealth funds, state retirement and pension systems, high net worth family offices, superannuation funds and foundations, and former portfolio company CEOs. The fund will focus on investments in companies with EBITDA of at least $5 million. As part of the closing, the fund acquired equity stakes from ACAS in eight companies: Mirion Technologies, SMG, Affordable Care, WRH, Potpourri, Avalon, FAMS and CIBT.